Benutzer: Gast  Login
Dokumenttyp:
journal article 
Autor(en):
Brill, TH; Kübler, HR; von Randenborgh, H; Fend, F; Pohla, H; Breul, J; Hartung, R; Paul, R; Schendel, DJ; Gansbacher, B 
Titel:
Allogeneic retrovirally transduced, IL-2- and IFN-gamma-secreting cancer cell vaccine in patients with hormone refractory prostate cancer--a phase I clinical trial. 
Abstract:
BACKGROUND: The purpose of this vaccine study was to determine the safety and feasibility of vaccination with an allogeneic prostate carcinoma cell line, LNCaP, expressing recombinant interleukin-2 (IL-2) and interferon-gamma (IFN-gamma) and to evaluate the efficacy of inducing tumor-specific immune responses in HLA-A2-matched patients with hormone refractory prostate cancer (HRPC). METHODS: In a dose-escalating phase I study, HLA-A2-matched HRPC patients received four vaccinations of irradiated...    »
 
Zeitschriftentitel:
J Gene Med 
Jahr:
2007 
Band / Volume:
Heft / Issue:
Seitenangaben Beitrag:
547-60 
Sprache:
eng 
Print-ISSN:
1099-498X 
TUM Einrichtung:
r experimentelle Onkologie und Therapieforschung; r Allgemeine Pathologie und pathologische Anatomie